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A most critical reaction in the complement system for the elaboration of its biologic 
effects is the cleavage of the third component, C3, whose major fragment, C3b, can 
covalently bind (1)  to target particles and soluble complexes. The bound C3b, or its 
degradation  products,  C3bi  and  C3d,  can  then  mediate  attachment  of the  target 
material to erythrocytes (2) and immunologic effector cells, such as B lymphocytes (3, 
4),  macrophages  (5,  6),  and  polymorphonuclear leukocytes  (PMN), 1 which  have 
specific  membrane  receptors  for these  fragments of C3.  These  adherence  reactions 
have been shown to promote, but generally not to mediate, the phagocytosis of bound 
material  by  PMN  and  macrophages  (7-10),  to  induce  secretion  of a  chemotactic 
lymphokine  by  B  lymphocytes  (11),  and  to  have  roles  in  the  development  of B 
lymphocytes into memory cells (12)  and antibody-secreting cells  (13-15). 
The receptor for C3b on human erythrocytes has been isolated and identified as a 
glycoprotein of --205,000 mol wt (16,  17), a finding that has recently been confirmed 
(18).  Its identity as  the C3b receptor also of PMN, monocytes, and  B  lymphocytes 
was  established  when  monospecific  rabbit  antibody  to  the  purified  erythrocyte 
glycoprotein inhibited the capacity of these cells to form rosettes with sheep erythro- 
cytes bearing C3b by binding to an externally oriented membrane protein of 205,000 
mol wt on each of these cell types (17,  18). The possibility that the C3b receptor was 
associated with  specialized  regions of the  plasma  membrane was suggested by the 
clustered distribution of fluorescein-conjugated Fab' anti-C3b receptor on PMN and 
monocytes, and by the apparent absence of lateral diffusive motion of the receptors 
as assessed by fluorescence photobleaching recovery experiments  (19).  Because other 
types of membrane receptors that exhibit clustered distributions, such as low density 
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lipoprotein  receptors  on  fibroblasts  (20),  mediate  adsorptive  endocytosis  of  their 
ligands, a  similar functional capacity for C3b receptors on PMN  was sought. 
Materials  and  Methods 
Preparation of Antibodies.  Antibody to human C3b receptor was prepared by immunizing a 
rabbit with C3b  receptor that  had been purified to homogeneity from detergent-solubilized 
human erythrocyte membrane proteins (16,  17). The monospecificity of this rabbit antibody 
for the C3b receptor has been previously established and is based on the following observations. 
The antibody inhibits the capacities of human erythrocytes, PMN, monocytes, and B lympho- 
cytes to form rosettes with sheep erythrocytes (E) bearing C3b, and has no effect on C3bi and 
C3d receptor-dependent reactions; there is specific binding of the antibody by these four cell 
types expressing C3b receptors and not by peripheral blood T  lymphocytes; and the antibody 
immunoprecipitates a  single membrane protein of 205,000  mol wt from cells expressing C3b 
receptors (17).  Antiserum to C3 was prepared by immunization of a  rabbit with purified C3 
(21). The IgG fractions of the rabbit antisera and of nonimmune rabbit serum were isolated by 
ammonium  sulfate precipitation and  anion-exchange chromatography. After digestion with 
pepsin  (Worthington  Biochemical Corp.,  Freehold,  N.  J.;  22),  the  F(ab~)2  fragments  were 
purified by gel filtration on Sephadex G-200 (Pharmacia Fine Chemicals, Piscataway, N. J.) 
and adsorption with Sepharose-protein A (Sigma Chemical Co., St. Louis, Mo.). Fab' anti-C3b 
receptor  and  anti-C3  were  prepared  by  mild  reduction  of the  F(ab')2  fragments  with  2- 
mercaptoethanol and alkylation with iodoacetamide (22).  Analysis of F(ab')2 and Fab' anti- 
C3b  receptor and  anti-C3  by  polyacrylamide gel electrophoresis in  the presence of sodium 
dodecyl sulfate (23) showed them to be free of detectable intact IgG. These antibody fragments 
and  goat  IgG anti-rabbit F(ab')2 (N.  L.  Cappel  Laboratories, Inc., Cochranville, Pa.)  were 
iodinated with lzsI and 131I (New England Nuclear, Boston, Mass.) to specific activities ranging 
from  150,000  cpm//zg  to  600,000  cpm/#g,  using  immobilized lactoperoxidase and  glucose 
oxidase  (Bio-Rad  Laboratories,  Richmond,  Calif.).  Goat  IgG  anti-rabbit  F(ab')z was  also 
conjugated with  tetramethylrhodamine isothiocyanate (TRITC;  Baltimore Biological Lab., 
Cockeysville, Md.; 24). 
Preparation of tz~I-C3b Bound to Constituents of Sheep E  Membranes (I~I-C3b-OR).  Human C3 
(21),  factor B (25),  factor D  (26),  and properdin (P; 26) were purified to homogeneity, and C3 
was  trace-labeled with  lesI  (New  England  Nuclear)  using iodogen  (Pierce Chemical Corp., 
Rockford, Ill.; 27) to specific activities ranging from 7.2 ×  104 cpm to 3.8 ×  l0  b cpm/#g without 
loss  of functional activity. Veronal-buffered saline, pH  7.5,  containing 0.1%  gelatin (GVB), 
GVB mixed with an equal volume of 5% dextrose in water, and containing 0.5 mM MgCI2 and 
0.15 mM CaC12 (DGVB  ++) were used as diluents (28). 
The  major  cleavage  fragment  of  C3,  C3b-OR,  that  is  bound  to  sheep  E  membrane 
constituents, was prepared by a two-step procedure (29).  2 ×  101° sheep E were incubated for 
o  125  30 min at 30  C  with 5,600 #g C3, 80 #g  I-C3,  1,200/.tg  factor B,  10 pg factor D, and  10/zg 
P  in 2 ml DGVB +÷ containing 5 mM MgCIe. The cells bearing C3b were washed five times 
with DGVB ÷+, and then incubated with 200 #g B,  10 #g D, and  10/~g P in 1 ml DGVB +÷ for 
30 min at 30°C to form cellular intermediate-bearing P-stabilized amplification C3 convertase 
sites, C3b,Bb,P. These cells were centrifuged, resuspended in  1 ml cold DGVB ÷+ containing 
600 #g levi-C3, incubated for 30 min at 30°C for the second stage of x25I-C3b deposition, and 
were washed three times with GVB. Solubilized membrane-bound t25I-C3b-OR was prepared 
by lysing 1 ×  10 x° sheep E 125I-C3b in 5 ml of ice-cold 5 mM NaPO4, pH 6.9, containing 1 mg/ 
ml  soybean  trypsin  inhibitor and  2  mg/ml  lima bean  trypsin  inhibitor.  The  lysates were 
centrifuged  at  149,000  g  for  60  rain  at  4°C  in  a  Beckman  ultracentrifuge,  model  L2-65B 
(Beckman Instruments Inc., Fullerton, Calif.), the pelleted membranes were resuspended in 5 
ml of the same buffer and centrifuged again. The washed membranes were incubated for 30 
min at 30°C in 4 ml veronal-buffered saline containing 0.25%  Nonidet P-40 (BDH Chemical 
Ltd., Poole, England) and were then subjected to centrifugation at 149,000 g for 60 min at 4°C. 
125  The  supernate-containing  solubilized  I-C3b-OR  was  concentrated  fourfold  by  negative 
pressure filtration with a collodion bag (Schleicher and Schuell Inc., Keene, N. H.), and excess 
Nonidet P-40 was removed by adsorption with Bio-Beads SM-2 (Bio-Rad Laboratories). The 
preparations were sonicated for 5 s at a setting of 6 on a Branson Sonifier Cell Disrupter, model DOUGLAS T.  FEARON, ISAO KANEKO, AND GEORGE  G.  THOMSON  1617 
350  (Branson Sonic Power Co., Danbury, Conn.), and were stored at -70°C.  After thawing 
and  before  use  in  binding  experiments,  the  preparations  were  again  sonicated  as  above. 
Amounts of 125I-C3b-OR are expressed as #g of complement protein, disregarding the sheep E 
membrane constituents to which they are bound. 
Binding Assays.  PMN were isolated from citrated blood by dextran sedimentation of E and 
centrifugation of the leukocytes on Ficoll-Hypaque cushions (Pharmacia Fine Chemicals; 30). 
Residual E were hypotonically lysed and the PMN were washed in calcium- and magnesium- 
free Hanks' balanced salt solution (Microbiological Associates, Walkersville, Md.) containing 
2 mg bovine serum albumin (HBSS-BSA; Sigma Chemical Co.)  per ml. Cell concentrations 
were determined with a model ZF Coulter Counter (Coulter Electronics, Hialeah, Fla.). 
In standard antibody-binding assays, replicate samples of 5 ×  106 PMN in 1 ml HBSS-BSA 
were preincubated for 20 min at 37°C with 100/xg of unlabeled nonimmune F(ab')2 and anti- 
C3b  receptor F(ab')2, respectively. 125I-F(ab')2 or x25I-Fah' anti-C3b receptor in  1 ml  HBSS- 
BSA were then added to the replicate samples of cells and incubation continued for 20 min at 
0 or 37°C. The PMN were washed three times with 2 ml of ice-cold HBSS-BSA and resuspended 
with 200/~g of 131I-IgG anti-F(ab')2 in 2 ml HBSS-BSA. After incubation for 1 h  at 0°C, the 
cells were washed three times with ice-cold HBSS-BSA and assayed for bound  x~I and  xalI. 
Specific uptake of ~25I-F(ab')2 or ~25I-Fab' was calculated by subtracting the amount of these 
antibodies hound to cells that had been preincubated with immune F(ab')a from that bound to 
I  131  P  cells  preincubated  with  nonimmune  F(ab )2.  Specifically bound  I-IgG anti-F(ab )2  was 
calculated by subtracting the ~3~I taken up by PMN previously incubated only with nonimmune 
F(ab')2 from that bound to cells that had been incubated also with 125I-F(ab')2 or 125I-Fab'. 
Specific binding at equilibrium of l~I-C3b-OR to PMN was assayed by incubating replicate 
samples of 2.5 ×  106 PMN in 0.08 ml HBSS-BSA for 30 min at 0°C with  10/~g of anti-C3b 
receptor F(ab')2 or nonimmune  F(ab')2, followed by the addition of incremental amounts of 
x2SI-C3b-OR in  0.02  ml  HBSS-BSA.  After incubation  for  45  min  at  0  or 30°C,  duplicate 
samples of 0.04 ml from each reaction mixture were layered on 0.3 ml of a mixture of 8 vol of 
dibutylphthalate and 2 vol of dinonylphthalate in polyethylene microfuge tubes (Brinkmann 
Instruments,  Inc.,  Westbury,  N.  Y.).  The  tubes  were  centrifuged  for  75  s  at  8,000  g  in  a 
Beckman  B  microcentrifuge (Beckman Instruments Inc.) and cut just above the cell pellets, 
which were then assayed for ~25I. 
Immunofluorescent Studies.  For immunofluorescent studies, 5  ×  105  PMN  in 0.5  ml  HBSS- 
BSA were incubated with  10 #g nonimmune  F(ab')2,  10 #g anti-C3b receptor F(ab')2, 10 #g 
F(ab')2 anti-C3, and 20 #g anti-C3b receptor Fab', respectively, for 20 min at either 0 or 37°C. 
After the cells were washed twice with 2 ml ice-cold HBSS-BSA, they were resuspended with 
0.5 ml HBSS-BSA containing 200 p.g TRITC-IgG anti-F(ab')2 that had been preadsorbed with 
109 sheep E for 30 min at 0°C, and incubated at 0°C for 60 min. The PMN were washed twice 
with  HBSS-BSA and  were fixed by resuspension in 0.2  ml  HBSS containing 2.5%  parafor- 
maldehyde and further incubation for 30 min at 0°C. The PMN were examined for fluorescence 
by placing a  drop of cell suspensions on  microscope slides, overlaying with  coverslips, and 
observing at ×600 magnification with a Leitz fluorescence microscope (E. Leitz, Inc., Roekleigh, 
N. V.). 
Results 
Immunofluorescent Analysis of the Surface Distribution  of C3b Receptors on PMN..  PMN 
preincubated with nonimmune  Fab' or F(ab')2 at 0  or at 37°C  bound no detectable 
TRITC-IgG.  PMN  that  had taken  up  anti-C3b receptor Fab' at 0°C  demonstrated 
a  punctate,  clustered distribution of fluorescence that  was  most  apparent  when  the 
focal plane was  at  the upper or lower surfaces of the cells (Fig.  1);  only peripheral 
rims of patchy fluorescence were observed with the focal plane at the middle of cells 
(Fig.  1).  An  identical distribution of fluorescence  was  observed on  PMN  that  had 
been treated with  2.5%  paraformaldehyde at 0°C  for 20 min before binding of Fab' 
anti-C3b  receptor.  To  determine  whether  this  distribution  of C3b  receptors  was 
induced by prior uptake of C3b  by PMN  either in  vivo or during collection of the 1618  ADSORPTIVE ENDOCYTOSIS BY C3b  RECEPTORS 
Fro.  1.  Fluorescent  photomicrographs  of PMN that had been sequentially incubated at 0°C with 
Fab' anti-C3b receptor and TRITC-IgG anti-F(ab')2. The plane of focus is at the top (left and 
middle panels) and at the middle of the cells (right panel). 
PMN, cells were incubated with F(ab')2 anti-C3 at 0°C, washed, and incubated with 
TRITC-IgG anti-F(ab')2.  No immunofluorescence was observed on any PMN, sug- 
gesting that the clustered appearance of C3b receptors as demonstrated by anti-C3b 
receptor represented their native distribution. 
PMN incubated with F(ab')2 at 0°C also demonstrated patchy fluorescence (Fig. 
2a and b), whereas cells exposed to this bivalent ligand at 37°C had few fluorescence 
clusters, and some cells did not bind any detectable TRITC-IgG anti-F(ab')2 (Fig.  2e 
and f).  A  replicate sample of the PMN-bearing F(ab')2 anti-C3b receptor that had 
been taken up at 0°C was subsequently held at 37°C for 15 min, brought to 0°C, and 
was then incubated with TRITC-IgG anti-F(ab')2 at 0°C. Fewer fluorescent clusters 
were visible on these cells (Fig.  2c and d) compared with the number present on the 
cells  that  were  maintained  at  0°C  throughout the experiment  (Fig.  2a and  b).  No 
capping of fluorescence was observed, although clusters on some PMN appeared to 
be distributed to one side of the cell.  Thus, redistribution of the C3b receptor-F(ab')2 
complexes formed at 0°C to a cellular compartment not accessible to the fluorescent 
second antibody occurred during incubation of the cells  at 37°C. 
Adsorptive Endocytosis of F(ab')z  Anti-C3b Receptor by  PMN.  The  low  uptake  of 
TRITC-IgG anti-F(ab')2 by PMN  that  had  been  incubated  with  F(ab')2 anti-C3b 
receptor at 37 rather than at 0°C could have been secondary to impaired binding of 
the primary antibody or to its  internalization by the PMN, rendering it inaccessible DOUGLAS  T.  FEARON,  ISAO KANEKO, AND GEORGE G. THOMSON  1619 
Fic.  2.  Light (a, c, and e) and corresponding fluorescent (b, d, and f) photomicrographs of PMN 
that had been sequentially incubated  with F(ab')z anti-C3b receptor at 0°C, washed, and either 
held at that temperature  (a and b) or incubated  for 15 min at 37°C (c and d). PMN were also 
incubated for 20 min at 37"C with anti-C3b receptor (e and f). The PMN were then incubated with 
TRITC-IgG anti-F(ab')2. The plane of focus was at  the top of the cells and magnification is × 
~600. 
to the secondary antibody. To discriminate between these possible explanations, PMN 
that  had been incubated with incremental  amounts of 125I-F(ab')z anti-C3b receptor 
at  0  and at  37°C, respectively, were compared for their capacity to take up lSlI-IgG 
anti-F(ab')2 at 0°C. Binding of 125I-F(ab')z anti-C3b receptor to the cells was saturable 
at  both  temperatures,  and  a  larger  fraction  of the  input  was taken  up at  37  rather 
than  at  0°C  (Fig.  3).  The  amounts  of lalI-IgG  anti-F(ab')2  that  bound  to  PMN 
previously incubated  with  anti-C3b receptor at 0°C were such that an approximate 
2:1  molar ratio  of IgG to F(ab')z occurred over the entire  dose  range  of cell-bound 
F(ab')2 (Fig. 3). PMN that had taken up comparable amounts of 125I-F(ab')2 anti-C3b 
receptor  at  37°C  had  relatively  diminished  capacities  to bind  laXI-IgG anti-F(ab')2, 
and  there  was  an  inverse  relationship  between  the  number  of anti-C3b  receptor 
molecules/PMN and the molar ratio of cell-associated IgG to F(ab')2  (Fig.  3). 
To  examine  further  the  temperature  dependence  of the  inaccessibility  of PMN- 
bound anti-C3b receptor, seven replicate samples of 5 ×  106 PMN were each incubated 
for 20 rain at 0°C with  10 #g 125I-F(ab')2 anti-C3b  receptor and washed at 0°C.  Six 
samples were brought to 37°C by the addition  of 0.5  ml of pre-warmed  HBSS-BSA 
and one sample was held on ice in this buffer. At timed intervals  during incubation 1620  ADSORPTIVE ENDOCYTOSIS  BY  C3b  RECEPTORS 
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FIG. 3.  Comparison of the binding of 131I-IgG anti-F(ab')~ by PMN that had taken up variable 
amounts  of lzSI-F(ab% anti-C3b receptor  at  0 and  37°C,  respectively. Left  panel: PMN  were 
incubated  with  incremental  concentrations  of ~SI-F(ab')2 anti-C3b  receptor  at  0°C,  washed, 
incubated with excess 131I-IgG  anti-F(ab% at 0°C, and assessed for cell-associated 1251 (0) and 131I 
(O). Middle panel: the same as the experiment depicted in the left panel, except that the PMN were 
incubated with  ~zsI-F(ab% anti-C3b  receptor  at  37°C.  Right panel: dose-response relationship 
between  the number  of l~I-F(ab% molecules taken up  by PMN  at  0*C  (A)  and  37°C  (Er), 
respectively, and the molar ratio of cell-associated 131I-IgG  to 12SI-F(ab')~. 
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Fro. 4.  Time course of the effect of incubation at 37~C on the capacity  of PMN  bearing ~251- 
F(ab')2 anti-C3b  receptor  (O) that had been taken up at 0°C to bind lslI-IgG anti-F(ab')2 (O) at 
0°C. 
at  37°C,  individual samples of PMN  were rapidly cooled by addition of 1.5  ml ice- 
cold HBSS-BSA, and held at 0°C. After 30 min, all samples of cells were centrifuged 
at  4°C,  the  supernatant  fluids  were  removed,  and  the cells were  assessed  for  their 
capacity to bind t31I-IgG anti-F(ab')2 at 0°C.  PMN  bearing 51,000 molecules of t2sI- 
F(ab')2 anti-C3b  receptor/cell  and  held  at  0°C  throughout  the  experiment  bound 
94,000  molecules of x31I-IgG anti-F(ab')2/cell, yielding a  1.84:1  molar ratio of IgG to 
F(ab')2 (Fig. 4), which is similar to that observed in the experiment depicted in Fig. 
3. PMN  that were incubated at 37°C maintained their content of cell-associated anti- 
C3b  receptor but  rapidly and  progressively lost  much  of their capacity to  take  up 
anti-F(ab')2; the molar ratio of IgG to F(ab')2 had decreased to 0.57:1 with PMN  that 
had been incubated at 37°C  for 7.5 min  (Fig. 4). 
The effect of the valency of the anti-C3b receptor on subsequent  binding of anti- 
F(ab')2 by PMN was assessed by incubating cells for 20 min at 37°C with incremental 
concentrations of lZSI-F(ab')2 and 125I-Fab' anti-C3b receptor, respectively. The PMN 
were washed and incubated for  1 h  at 0°C with 131I-IgG anti-F(ab')2 and assessed for DOUGLAS T.  FEARON,  ISAO KANEKO,  AND GEORGE G.  THOMSON  1621 
cell-bound  1251 and  131I. Uptake  of bivalent  and  monovalent  anti-C3b  receptor  by 
PMN  were  saturable  reactions,  although  an  input  of 2.5  times  more  t25I-Fab' was 
necessary  to achieve binding  that  was equivalent  to that  observed  with  125I-F(ab')z 
(Fig. 5). The molar ratio of bound IgG to F(ab')2 decreased almost fivefold over the 
dose range of 10,000-42,000 molecules of anti-C3b receptor/PMN  (Fig. 5). However, 
binding  of increasing  amounts  of morovalent  anti-C3b  receptor  to  PMN  was  not 
associated with impaired  uptake of anti-F(ab')2 and the molar ratio of cell-bound to 
IgG to Fab' remained  in  the  range  of 2:1  over a  dose  range  of 22,000-74,000  125I- 
Fab'/PMN  (Fig. 5). 
The disparity in the accessibility to an extracellular  ligand of PMN-bound mono- 
valent and bivalent anti-C3b receptor was examined further by assessing the capacity 
of pronase to release these cell-associated antibody fragments.  PMN were incubated 
at 37°C for 20 min with incremental concentrations of 125I-F(ab')2 and lZ~I-Fab' anti- 
C3b receptor,  respectively, and were washed  and assayed for bound  125I. The PMN 
were then resuspended in  1 ml HBSS-BSA containing 500 ~g pronase/ml,  incubated 
for an additional  15 min at  37°C and centrifuged,  and the cell pellets were assayed 
for residual  125I. At the highest input of l~ZI-F(ab')2, 75,000 molecules were bound per 
PMN  and  79%  remained  cell-associated  after  treatment  with  pronase  (Fig.  6).  In 
contrast,  only  17%  of the  94,000  12SI-Fab' molecules/PMN  that  were bound  at  the 
highest  input  of the  monovalent  anti-C3b  receptor  remained  cell-associated  after 
treatment of the cells with pronase (Fig. 6). 
To assess the involvement of cytochalasin B-sensitive cytoskeletal elements in C3b 
receptor-mediated  endocytosis, 5  ×  106 PMN were incubated  for 10 min at  37°C in 
0.5  ml  HBSS-BSA containing  5 #g eytochalasin  B/ml  and 0.5%  dimethyl  sulfoxide 
(DMSO), and a  replicate sample of PMN was incubated with buffer containing only 
DMSO.  4  ~g of 125I-F(ab')2 anti-C3b  receptor  was  added  to each  reaction  mixture 
and incubation was continued for 20 min at 37°C, after which the cells were washed 
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Flo.  5.  Comparison of the binding of 131I-IGG  anti-F(ab)2 by PMN that had taken up variable 
125  amounts of 12nI-F(ab')2 and  I-Fab' anti-C3b receptor, respectively, at 37°C. Left panel:  PMN 
125  p  o  were incubated with incremental concentrations of  I-F(ab )2 anti-C3b receptor at 37  C, washed, 
131  incubated with excess  l-lgG at 0°C, and assessed for cell-associated ~2Sl (D) and 131I (O). Middle 
panel: the same as the experiment depicted in the left panel, except that the PMN were incubated 
with incremental concentrations of ~zsI-Fab'  anti-C3b receptor. Right panel: dose-response relation- 
ship between the number of l~5I-labeled F(ab')2 (V) and Fab' (A) molecules, respectively, taken up 
by PMN and the molar ratio of cell-associated 131I-IGG  to the anti-C3b receptor antibody fragment. 1622  ADSORPTIVE  ENDOCYTOSIS  BY  C3b  RECEPTORS 
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presence of non-immune F(ab')2 (solid lines) or anti-C3b receptor F(ab')2 (dashed lines). 
and assessed for their capacity to bind 13Xl-IgG anti-F(ab)~ at 0°C. PMN preincubated 
with buffer containing only DMSO and bearing 51,000 F(ab')2 molecules/cell subse- 
quently bound 31,280 IgG molecules/ceil, representing a 0.61:1  molar ratio of IgG to 
F(ab')2.  PMN  that  had taken up 45,300  molecules/cell of anti-C3b  receptor in  the 
presence of cytochalasin  B  bound  27,640  molecules/cell of anti-F(ab')2, yielding an 
identical 0.61:1  molar ratio of IgG to F(ab')2. 
Adsorptive Endocytosis of l~l-C3b-OR by PMN.  Incremental amounts of 12~I-C3b-OR 
that had been solubilized from sheep E membranes to which the complement protein 
had affixed were incubated at 0 or at 30°C for 45 min with PMN in the presence of 
nonimmune or anti-C3b receptor F(ab')2. Uptake of 125I-C3b-OR by the cells in the 
presence  of nonimmune  F(ab')2  was  slightly  greater  at  37  than  at  0°C,  and  the 
binding  curves  were  concave  to  the  abscissa  throughout  the  analyses,  indicating 
saturable  reactions  (Fig.  7).  In  contrast,  the  binding  of 12~I-C3b-OR to  PMN  was 
greatly diminished by the presence of anti-C3b receptor, was a linear function of the 
input of the ligand, and thus, was nonsaturable or nonspecific (Fig. 7). 
Internalization of 1251-C3b-OR by PMN was assessed by incubating 5 X  106 PMN 
in  1 ml HBSS-BSA with incremental amounts of the ligand for 20 min at 37°C. The 
cells were washed twice with 2 ml HBSS-BSA and were assayed for bound 125I-C3b- 
OR.  The cells were then suspended  in  1 ml HBSS-BSA containing  500 #g pronase 
and incubation was continued for 15 min at 37°C. After centrifugation and removal 
of the supernatant fluids, the cell pellets were assayed for residual-associated t25I-C3b- DOUGLAS  T.  FEARON,  ISAO  KANEKO,  AND  GEORGE  G.  THOMSON  1623 
OR. Greater than 90% of the radioactivity initially bound by the PMN at each input 
of the ligand was susceptible to release by pronase, indicating that the C3b receptor- 
ligand complex had remained at the cell surface (Fig. 8). 
Because bivalent, but not monovalent, anti-C3b receptor was internalized by C3b 
receptors, the effect of cross-linking l~SI-C3b-OR bound by PMN on the endocytosis 
of this ligand was examined. Replicate samples of 5 ×  106 PMN in  1 ml HBSS-BSA 
were each incubated for 45 min at 0°C with 0.27 #g 12aI-C3b-OR, and the cells were 
washed  twice  with  ice-cold  buffer  and  resuspended  in  1  ml  HBSS-BSA  alone  or 
containing  incremental  concentrations of Fab' or F(ab')2 anti-C3.  After incubation 
for 20 rain at 37°C, the PMN were washed twice at 0°C and assayed for cell-bound 
125I. The cells were then resuspended in  1 ml HBSS-BSA containing 500 gg pronase, 
incubated  for  15  min at  37°C,  centrifuged,  and assayed for residual-associated  125I 
after removal of the  supernatant  fluids.  Incubation  of PMN-bearing  125I-C3b-OR 
with monovalent or bivalent anti-C3 did not alter the amount of cell-bound radiola- 
beled ligand before treatment with pronase (Fig. 9). Fab' anti-C3 had only a minimal 
effect on the percentage of x25I-C3b-OR removed from the PMN by pronase, which 
was 91 and 85% with PMN that had been incubated with buffer and with the highest 
input  of monovalent  anti-C3,  respectively.  In  contrast,  F(ab')2  anti-C3  induced  a 
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Fic.  8.  Dose response relationship between input of a~%C3b-OR and the number of molecules 
taken  up  by  PMN  at  37°C  (0)  and remaining bound  after treatment of the cells with pronase 
(0). 
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FIG.  9.  Dose-response relationship between the amounts of Fab'  (left panel) and  F(ab')2  (right 
panel) anti-C3 that were incubated for 20 min at 37  C  with PMN-bearing  I-C3b-OR and the 
number of molecules of 12ZI-C3b-OR  per cell before (0)  and after (O)  treatment of the cells with 
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dose-related increase in  the amount  of x25I-C3b-OR remaining cell-associated after 
pronase treatment,  so  that  only 20-30%  of the  ligand  was  released  by proteolytic 
treatment of cells that had been exposed to the highest concentrations of the bivalent 
anti-C3 (Fig. 9). 
Discussion 
The capacity of C3b receptors on PMN to mediate internalization at 37°C of 1251- 
F(ab')z  anti-C3b  receptor was  established  by  the  relative  inaccessibility  of ligand 
taken  up  at  37°C  to  two extracellular probes,  IgG anti-F(ab')2  and  pronase.  The 
F(ab')2  fragments  were  separated  from  residual  intact  IgG  by  gel  filtration  and 
adsorption  with  Sepharose-protein  A,  and  no  intact  heavy  chains  were  seen  on 
polyacrylamide gel electrophoresis; thus, internalization of the antibody by Fc recep- 
tors  was  excluded.  The  clusters  of C3b  receptors  that  were  observed  by  indirect 
immunofluorescence of PMN  that  had  been bound anti-C3b  receptor at 0°C  were 
almost  absent on cells that  had been incubated with the antibody at  37°C,  which 
suggests that endocytosis of the antibody had occurred at the higher temperature (Fig. 
2).  This  possibility  was  confirmed  and  quantitated  in  dose-response  experiments 
measuring  the sequential  uptake by PMN  of 125I-F(ab')2  anti-C3b  at  0  and  37°C, 
respectively, and of 131I-IGG anti-F(ab')2 at 0°C. Each molecule of anti-C3b receptor 
bound by PMN at 0°C subsequently took up an average two molecules ofanti-F(ab')2 
over the entire dose-range of cell-associated 125I-F(ab')z, establishing a 2:1 molar ratio 
of cell-bound  IgG  to  F(ab')2  under  conditions  that  excluded  receptor-mediated 
endocytosis.  In  contrast,  when  increments  of anti-C3b  receptor were  taken  up  by 
PMN at 37°C, there was a  progressive decline in the capacity of the cell-associated 
antibody to bind IgG anti-F(ab')2. A cell-bound molar ratio of only 0.2 IgG molecules/ 
F(ab')z  occurred  with  PMN  that  had  taken  up  the  highest  number  of anti-C3b 
receptor molecules at 37°C and this is taken to indicate that 90% of the ligand bound 
to C3b receptors had been endocytosed. Anti-C3b receptor bound to PMN at 0°C 
rapidly became inaccessible to the second antibody during incubation of the cells at 
37°C,  with  a  half-time  for  internalization  of <5  min  (Fig.  4),  indicating  that 
endocytosis was  stimulated  by the  ligand,  rather  than  being secondary to  normal 
metabolic turnover of the receptor. 
The increasing proportion of F(ab')2 anti-C3b receptor that was rendered inacces- 
sible to anti-F(ab')2 when larger amounts of the primary antibody were taken up by 
PMN at 37°C  (Fig. 3) suggested that muhivalent interaction of this ligand with the 
receptor was required to stimulate  internalization.  Incubation of PMN with  incre- 
mental amounts of monovalent 125I-Fab' anti-C3b receptor at 37°C was not associated 
with  impaired  subsequent  uptake  of 131I-IgG anti-F(ab')z  as  a  relatively constant 
molar ratio of two IgG bound/Fab' was observed (Fig. 5). Moreover, treatment with 
pronase of PMN-bearing 12~I-Fab' anti-C3b receptor that had been taken up at 37°C 
removed >80%  of the  cell-bound  1251, whereas,  in  a  parallel  experiment,  pronase 
treatment of PMN that had bound 76,000 125I-F(ab')z anti-C3b receptor molecules/ 
cell released only 25% of the cell-associated 125I (Fig. 6). Thus, cross-linking of C3b 
receptors by ligand appears to be necessary for the pinocytotic reaction. 
The capacity of C3b receptors on PMN to mediate internalization of the bivalent 
antibody fragment prompted an examination of their interaction with  the natural 
ligand, C3b. This cleavage fragment of C3 may be present in its free form, C3b, in DOUGLAS  T.  FEARON,  ISAO  KANEKO,  AND  GEORGE  G.  THOMSON  1625 
which  a  carbonyl that  is derived from an  internal  thioester  (31)  has  reacted with 
H20, or in a state designated as C3b-OR, in which the carbonyl has formed an ester 
linkage to constituents of the immune complex bearing the C3 convertase (1).  C3b- 
OR, rather than free C3b, was used in these studies because 15-80% of the former has 
been shown to be capable of binding to C3b receptors on human erythrocytes, whereas 
<1% of the latter had this activity.  2 125I-C3b-OR was bound by PMN in a saturable 
reaction  that  was  abolished  by preincubation  of the  cells  with  anti-C3b  receptor 
F(ab')2, indicating that both ligands interacted with the same cell surface structure 
(Fig.  7).  Because treatment  with pronase of PMN bearing incremental amounts of 
12SI-C3b-OR that had been taken up during incubation at 37°C released >90% of the 
cell-associated  125I, this  monovalent  receptor-ligand  complex was  not  internalized 
(Fig. 8). Cross-linking of the bound a25I-C3b-OR by introducing increasing amounts 
of F(ab')2  anti-C3  to  create  muhivalent  ligands,  however, induced  a  dose-related 
increase in the amount of the complement protein that was inaccessible to proteolytic 
stripping  (Fig.  9).  Thus, the natural ligand  for C3b receptors on PMN  elicited an 
endocytotic response when presented as a  muhivalent structure, as had antibody to 
the receptor. 
The C3b receptor of PMN has been considered to participate only in the attachment 
phase of endocytosis because these cells bind, but do not internalize, sheep E bearing 
C3b  (9,  10);  phagocytosis occurs only when  targets  also  carry IgG, which  permits 
their  interaction  with  Fc  receptors  on  PMN.  However,  the  finding  that  PMN 
internalized F(ab')2 anti-C3b receptor and C3b-OR that had been cross-linked with 
anti-C3,  indicates  that  C3b  receptors  are  capable  of mediating  internalization  of 
soluble,  rather  than  particulate,  ligand  by  adsorptive  pinocytosis.  A  distinction 
between  these  two  types  of endocytotic reactions could  reside  in  the  cytoskeletal 
elements that are involved, because cytochalasin B, which impairs phagocytosis (32), 
had  no  inhibitory  effects  on  internalization  of F(ab')2  anti-C3b  receptor,  which 
suggests  that  the  latter reaction is  not  mediated  by microfilaments. A  cytoplasmic 
structural protein possibly involved in C3b receptor-mediated endocytosis is clathrin, 
because endocytotic receptors on other cell types accumulate in clathrin-coated pits 
(20, 33), which yield a clustered distribution of receptors similar to that observed for 
the C3b receptor (Figs.  1 and 2). Regardless of the mechanism, the demonstration of 
this functional capacity for C3b receptors indicates that they can directly mediate the 
clearance of C3b-bearing soluble complexes. 
Summary 
C3b receptors on human polymorphonuclear leukocytes (PMN) were nonrandomly 
distributed in small clusters on the plasma membranes of these cells when assessed by 
indirect immunofluorescence at 0°C using monospecific rabbit Fab' or F(ab')2 anti- 
C3b  receptor and  tetramethylrhodamine isothiocyanate  (TRITC)-conjugated goat 
IgG anti-F(ab')2. When PMN were incubated with the bivalent anti-C3b receptor at 
37 rather than at 0°C, almost no immunofiuorescence was observed, which indicates 
that the C3b receptor-F(ab')2 complexes had been rendered inaccessible to TRITC- 
IgG  anti-F(ab')2.  Endocytosis of the  anti-C3b  receptor ligand  was  quantitated  by 
2 Kaneko, I., and D. T. Fearon. The human erythrocyte receptor for C3b, the major cleavage fragment 
of the third component of complement: specificity for the covalently bound form of C3b.  Manuscript 
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measuring the binding  131I-IgG anti-F(ab')z by PMN that  had  previously taken up 
azSI-F(ab')z anti-C3b receptor at 0 and at 37°C, respectively. There was a constant 2: 
1 molar ratio of anti-F(ab')2 to anti-C3b receptor with PMN that had been incubated 
with  the  first  antibody  at  0°C.  In  contrast,  when  increments  of F(ab')2  anti-C3b 
receptor were taken up by the cells at 37°C, there was a  dose-related decline in this 
molar ratio to  a  minimum  of 0.2  molecules of anti-F(ab')z bound  per molecule of 
PMN-associated anti-C3b receptor. 12SI-F(ab')2  anti-C3b receptor taken up by PMN 
at  37°C  was  also  inaccessible  to  release  by proteolytic  treatment  of the  cells  with 
pronase.  The rate of endocytosis of lzSI-F(ab')2 anti-C3b  receptor was  rapid  as  the 
PMN-bound  antibody fragment became inaccessible to 131I-IgG anti-F(ab')2 within 
10 min during incubation of the cells at 37°C. In contrast to these findings, 125I-Fab' 
anti-C3b receptor that was taken up by PMN at  37°C  remained accessible to both 
181I-IgG  anti-F(ab')2  and  to  proteolytic  release  by  pronase,  which  suggests  that 
monovalent interaction of ligand with C3b receptors was not sufficient for induction 
of endocytosis. The requirement  for multivalency was also demonstrated  using the 
C3b-OR, the normal ligand for the C3b receptor. 125I-C3b-OR was specifically bound 
by  PMN  but  remained  on  the  cell  surface,  as  determined  by  its  accessibility  to 
pronase, unless  it was cross-linked with F(ab')2 anti-C3.  Although C3b receptors on 
PMN  do  not  mediate internalization  of particulate  ligand,  their  newly recognized 
capacity to  function  in  receptor-mediated  adsorptive  pinocytosis of soluble  ligand 
indicates their potential for the clearance of C3b-bearing immune complexes without 
recruitment of other cell surface receptors. 
Received  for publication 22January  1981 and in revised  form 9 March  1981. 
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